Estramustine sodium phosphate

CAS: 52205-73-9

Ref. 3D-FE15526

Informação sobre produto

• Nome: Estramustine sodium phosphate
• Sinónimos: (17-Beta)-Estra-1,3,5(10)-Triene-3,17-Diol 3-(Bis(2-Chloroethyl)Carbamate) 17-(Dihydrogenphosphate) Disodium Salt, Disodium (17Beta)-3-{[Bis(2-Chloroethyl)Carbamoyl]Oxy}Estra-1,3,5(10)-Trien-17-Yl Phosphate, Emcyt, Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-[N,N-bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), sodium salt (1:2), Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), disodium salt, Estracyt, Estramustine Phosphate Sodium, Estramustine disodium phosphate, Estramustine phosphate disodium, Estramustine phosphate disodium salt, Ro 21-8837/001

Descrição

Estramustine is a cytotoxic agent that inhibits the growth of cancer cells by interfering with intracellular targets. It is classified as an alkylating agent, which means it damages DNA and RNA by binding to them. Estramustine can be used in chemotherapy for the treatment of various types of cancers, including prostate cancer. This drug has minimal toxicity and long-term toxicity effects on the prostate gland, which limits its use in treating prostate cancer. Estramustine phosphate also inhibits a protein that helps maintain cellular calcium levels and can be used as an anti-inflammatory agent.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 566.36 g/mol
• Fórmula: C₂₃H₃₂NO₆Cl₂Na₂P
• Pureza: Min. 98 Area-%
• Cor/forma: Powder